drugset / Trial / NCT00018161

Treatment to Quit Smoking

NCT00018161 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

This protocol evaluates the efficacy of combining pharmacologic treatments for smoking cessation, entailing the use of the nicotine skin patch with the nicotinic antagonist mecamylamine, with a specific behavioral therapy designed to inhibit the smoking urge.

Timeline

Start
1997-01
Primary completion
—
Completion
2001-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Mecamylamine Small molecule — —
Subject Nicotine Unknown — Other

Indications

No indication recorded.